Risk Factors for Septic Arthritis After Anterior Cruciate Ligament Reconstruction: A Nationwide Analysis of 26,014 ACL Reconstructions.


Journal

The American journal of sports medicine
ISSN: 1552-3365
Titre abrégé: Am J Sports Med
Pays: United States
ID NLM: 7609541

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 26 3 2021
medline: 29 6 2021
entrez: 25 3 2021
Statut: ppublish

Résumé

Septic arthritis (SA) after anterior cruciate ligament reconstruction (ACLR) is a rare yet severe complication. The samples in previous studies have been small and without nationwide coverage, making analysis uncertain with a risk of bias. Conclusions to recommend preventive measures are therefore difficult to draw, and it has not been possible to perform a comprehensive risk factor analysis. To study the incidence of SA after ACLR in a large, nationwide population and to study the risk factors for SA after ACLR. Case-control study; Level of evidence, 3. All ACLRs, primary and revision, in the Swedish Knee Ligament Registry between 2006 and 2013 were linked with data from the Swedish National Board of Health and Welfare. The incidence of SA events was determined using entries from the day of surgery until 90 days postoperatively based on diagnosis codes and the prescription of antibiotics. All events of SA were verified via a review of medical records. Risk factors were analyzed based on data from the registries. Descriptive statistics were used to describe the findings, while logistic regression analysis was used for the risk analysis. The cohort consisted of 26,014 primary and revision ACLRs. During the study period, 298 events of SA (1.1%) were identified. The high-volume units (≥500 ACLRs during the study period) had a distribution of SA between 2 and 47 (0.2%-2.9%). Independent risk factors of SA were male sex (OR, 1.65; 95% CI, 1.28-2.13), operating time ≥70 minutes (OR, 1.83; 95% CI, 1.42-2.36), hamstring tendon autograft (OR, 2.23; 95% CI, 1.21-4.08), and clindamycin as perioperative antibiotic prophylaxis (OR, 1.94; 95% CI, 1.10-3.41). The incidence of SA after ACLR in this nationwide cohort was 1.1%. Male sex, hamstring tendon autografts, and a longer operating time were all independent risk factors for SA. The use of clindamycin as perioperative antibiotic prophylaxis was a risk factor compared with the use of cloxacillin. Some high-volume units had a very low infection rate (0.2%).

Sections du résumé

BACKGROUND
Septic arthritis (SA) after anterior cruciate ligament reconstruction (ACLR) is a rare yet severe complication. The samples in previous studies have been small and without nationwide coverage, making analysis uncertain with a risk of bias. Conclusions to recommend preventive measures are therefore difficult to draw, and it has not been possible to perform a comprehensive risk factor analysis.
PURPOSE
To study the incidence of SA after ACLR in a large, nationwide population and to study the risk factors for SA after ACLR.
STUDY DESIGN
Case-control study; Level of evidence, 3.
METHODS
All ACLRs, primary and revision, in the Swedish Knee Ligament Registry between 2006 and 2013 were linked with data from the Swedish National Board of Health and Welfare. The incidence of SA events was determined using entries from the day of surgery until 90 days postoperatively based on diagnosis codes and the prescription of antibiotics. All events of SA were verified via a review of medical records. Risk factors were analyzed based on data from the registries. Descriptive statistics were used to describe the findings, while logistic regression analysis was used for the risk analysis.
RESULTS
The cohort consisted of 26,014 primary and revision ACLRs. During the study period, 298 events of SA (1.1%) were identified. The high-volume units (≥500 ACLRs during the study period) had a distribution of SA between 2 and 47 (0.2%-2.9%). Independent risk factors of SA were male sex (OR, 1.65; 95% CI, 1.28-2.13), operating time ≥70 minutes (OR, 1.83; 95% CI, 1.42-2.36), hamstring tendon autograft (OR, 2.23; 95% CI, 1.21-4.08), and clindamycin as perioperative antibiotic prophylaxis (OR, 1.94; 95% CI, 1.10-3.41).
CONCLUSION
The incidence of SA after ACLR in this nationwide cohort was 1.1%. Male sex, hamstring tendon autografts, and a longer operating time were all independent risk factors for SA. The use of clindamycin as perioperative antibiotic prophylaxis was a risk factor compared with the use of cloxacillin. Some high-volume units had a very low infection rate (0.2%).

Identifiants

pubmed: 33764802
doi: 10.1177/0363546521993812
pmc: PMC8182335
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1769-1776

Références

Knee Surg Sports Traumatol Arthrosc. 2018 Feb;26(2):558-562
pubmed: 28988312
Arthroscopy. 2014 Sep;30(9):1100-9
pubmed: 24836173
J Knee Surg. 2017 Jul;30(6):535-543
pubmed: 27780287
Knee Surg Sports Traumatol Arthrosc. 2013 Dec;21(12):2844-9
pubmed: 23104168
Am J Sports Med. 2016 Jan;44(1):99-104
pubmed: 26526974
Acta Orthop. 2017 Oct;88(5):562-567
pubmed: 28492106
Am J Sports Med. 2019 Jan;47(1):104-111
pubmed: 30481480
Orthop J Sports Med. 2019 Feb 19;7(2):2325967118825453
pubmed: 31001565
Am J Sports Med. 2010 Feb;38(2):281-6
pubmed: 19915101
Drugs. 2006;66(8):1089-105
pubmed: 16789794
Arthroscopy. 2012 Mar;28(3):337-42
pubmed: 22112612
Int Orthop. 2016 Mar;40(3):607-14
pubmed: 26239533
Am J Sports Med. 2013 Aug;41(8):1780-5
pubmed: 23749343
Am J Sports Med. 2018 May;46(6):1500-1508
pubmed: 28737955
Am J Sports Med. 2014 Oct;42(10):2319-28
pubmed: 25201444
World J Orthop. 2018 Nov 18;9(11):262-270
pubmed: 30479973
Orthop J Sports Med. 2019 Sep 25;7(9):2325967119871038
pubmed: 31598528
J Bone Joint Surg Am. 2013 May 1;95(9):843-9, S1-6
pubmed: 23636192
Surg Infect (Larchmt). 2017 Aug/Sep;18(6):722-735
pubmed: 28832271
J Bone Joint Surg Am. 2009 Jan;91(1):38-47
pubmed: 19122077
Circulation. 2003 Jun 17;107(23 Suppl 1):I9-16
pubmed: 12814980
Am J Sports Med. 2014 Oct;42(10):2363-70
pubmed: 25086064
Infect Dis Clin North Am. 2017 Jun;31(2):203-218
pubmed: 28366221
J Bone Joint Surg Am. 2013 May 1;95(9):775-82
pubmed: 23636183
J Bone Joint Surg Am. 2015 Mar 18;97(6):450-4
pubmed: 25788300
Am J Sports Med. 2015 Mar;43(3):641-7
pubmed: 25548148
Bone Joint J. 2016 Aug;98-B(8):1014-9
pubmed: 27482011
BMC Infect Dis. 2017 Oct 12;17(1):680
pubmed: 29025402
Bone Joint J. 2016 May;98-B(5):608-15
pubmed: 27143730
Arthroscopy. 2019 Jul;35(7):2089-2098
pubmed: 31227396
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213
Am J Sports Med. 2018 Mar;46(4):846-851
pubmed: 29298084
Knee Surg Sports Traumatol Arthrosc. 2020 Aug;28(8):2535-2542
pubmed: 32025765
Bone Joint J. 2019 Jan;101-B(1):34-40
pubmed: 30601041
Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):726-35
pubmed: 16897791

Auteurs

Jesper Kraus Schmitz (J)

Stockholm Sports Trauma Research Center, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Orthopaedics, Skåne University Hospital, Malmö, Sweden.

Viktor Lindgren (V)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Orthopaedics, Karolinska University Hospital, Stockholm, Sweden.

Gunnar Edman (G)

Research and Development, Norrtälje Hospital, Tiohundra AB, Norrtälje, Sweden.
Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Per-Mats Janarv (PM)

Stockholm Sports Trauma Research Center, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Capio Artro Clinic, Stockholm, Sweden.

Magnus Forssblad (M)

Stockholm Sports Trauma Research Center, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Anders Stålman (A)

Stockholm Sports Trauma Research Center, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Capio Artro Clinic, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH